This event is archived. Final snapshot from when the story concluded. View on Dashboard
Tech medical diagnosis

Deb Gascoyne's Myeloma Journey and Fundraising

Analysis based on 6 articles · First reported Jan 14, 2026 · Last updated Jan 18, 2026

Sentiment
20
Attention
0
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

This event has no direct impact on financial markets. It highlights the ongoing need for research and funding in the healthcare and pharmaceutical industries, particularly for conditions like Multiple myeloma.

Healthcare Pharmaceuticals Non-profit

Deb Gascoyne, a 50-year-old mother of two, was diagnosed with smouldering myeloma, an early form of blood cancer, in July 2009 after a precautionary blood test. The diagnosis, initially given when she was 34, led to fears about her life expectancy. Her condition progressed to active Multiple myeloma, and she has since undergone chemotherapy and two stem cell transplants. Despite relapsing twice, Deb Gascoyne has dedicated herself to fundraising for Myeloma UK, raising £248,100 towards a £250,000 target to support research into treatments and a cure. She is preparing for her final fundraising challenge, a cycle from London to Paris, in May. Deb Gascoyne's story emphasizes the importance of early diagnosis and the ongoing fight against cancer.

per
Deb Gascoyne was diagnosed with smouldering myeloma, which progressed to active cancer. She has undergone multiple treatments and is actively fundraising for Myeloma UK.
Importance 100.0 Sentiment 70.0
ngo
Myeloma UK is the charity for which Deb Gascoyne is fundraising, supporting research into myeloma treatments and providing a support network for patients.
Importance 80.0 Sentiment 50.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.